No abstract available
Keywords:
Anti-TNF; Cardiovascular disease; JAK inhibitor; Major adverse cardiovascular events; Rheumatoid arthritis; Tofacitinib.
MeSH terms
-
Antirheumatic Agents* / therapeutic use
-
Arthritis, Rheumatoid* / drug therapy
-
Humans
-
Pyrroles / therapeutic use
Substances
-
Antirheumatic Agents
-
Pyrroles